A pharmaceutical composition for inhibiting at least one of histone gene transcription and histone expression is provided. The pharmaceutical composition comprises an effective amount of an active component selected from a group consisting of a compound of formula (I), a pharmaceutically acceptabie salt of the compound, and combinations thereof:

A pharmaceutical composition for inhibiting at least one of histone gene transcription and histone expression is provided. The pharmaceutical composition comprises an effective amount of an active component selected from a group consisting of a compound of formula (I), a pharmaceutically acceptabie salt of the compound, and combinations thereof:

A pharmaceutical composition for inhibiting at least one of histone gene transcription and histone expression is provided. The pharmaceutical composition comprises an effective amount of an active component selected from a group consisting of a compound of formula (I), a pharmaceutically acceptabie salt of the compound, and combinations thereof:

本發明係關於抑制組蛋白基因轉錄及/或抑制組蛋白表現之醫藥組合物，尤其是關於抑制細胞異常增生、治療蟹足腫及口腔黏膜下纖維化症之醫藥組合物。